deltatrials
Completed NA INTERVENTIONAL NCT00005994

Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy

Patient Information and Antiemetic Drug Efficacy

Sponsor: National Cancer Institute (NCI)

Conditions Nausea and Vomiting Unspecified Adult Solid Tumor, Protocol Specific
Interventions ondansetron
Updated 5 times since 2017 Last updated: Mar 4, 2013 Started: Aug 31, 2000 Primary completion: Jul 31, 2001 Completion: Jul 31, 2001
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Nausea and Vomiting and Unspecified Adult Solid Tumor, Protocol Specific and is currently completed. National Cancer Institute (NCI) leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Aug 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Rochester
Data source: University of Rochester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations